| histone methylation | GO:0016571 | 71 | 0.990 | |
| dna metabolic process | GO:0006259 | 303 | 0.972 | |
| dna methylation | GO:0006306 | 43 | 0.921 | |
| chromatin modification | GO:0016568 | 187 | 0.919 | |
| histone h3 k9 dimethylation | GO:0036123 | 4 | 0.899 | |
| chromatin organization | GO:0006325 | 206 | 0.867 | Fly |
| protein alkylation | GO:0008213 | 81 | 0.855 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.841 | |
| dna hypermethylation | GO:0044026 | 3 | 0.836 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.832 | Human |
| regulation of histone methylation | GO:0031060 | 30 | 0.815 | |
| macromolecule methylation | GO:0043414 | 120 | 0.806 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.798 | |
| histone lysine methylation | GO:0034968 | 50 | 0.794 | |
| negative regulation of mrna processing | GO:0050686 | 12 | 0.773 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.749 | |
| dna modification | GO:0006304 | 50 | 0.744 | |
| dna repair | GO:0006281 | 107 | 0.686 | Human |
| nucleoside metabolic process | GO:0009116 | 246 | 0.666 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.665 | |
| histone modification | GO:0016570 | 159 | 0.646 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.645 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.642 | |
| spermatogenesis | GO:0007283 | 284 | 0.629 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.610 | Mouse |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.606 | Human Mouse |
| histone deubiquitination | GO:0016578 | 2 | 0.580 | |
| positive regulation of histone methylation | GO:0031062 | 16 | 0.569 | |
| dna alkylation | GO:0006305 | 43 | 0.556 | |
| gene silencing | GO:0016458 | 38 | 0.544 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.536 | |
| chromatin assembly | GO:0031497 | 13 | 0.535 | |
| amine metabolic process | GO:0009308 | 45 | 0.533 | |
| methylation | GO:0032259 | 134 | 0.530 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.518 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.513 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.504 | |
| regulation of histone modification | GO:0031056 | 56 | 0.501 | |
| protein methylation | GO:0006479 | 81 | 0.493 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.469 | |
| histone h3 k9 methylation | GO:0051567 | 17 | 0.458 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.451 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.448 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.442 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.441 | |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.433 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.399 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.397 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.387 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.385 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.368 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.366 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.359 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.358 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.343 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.341 | |
| negative regulation of mrna splicing via spliceosome | GO:0048025 | 12 | 0.326 | |
| chromatin silencing | GO:0006342 | 15 | 0.322 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.312 | Human |
| viral life cycle | GO:0019058 | 36 | 0.307 | Human |
| ras protein signal transduction | GO:0007265 | 77 | 0.305 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.302 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.297 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.294 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.288 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.282 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.281 | |
| meiosis i | GO:0007127 | 60 | 0.278 | |
| male gamete generation | GO:0048232 | 285 | 0.273 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.272 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.269 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.268 | |
| rna processing | GO:0006396 | 105 | 0.260 | |
| negative regulation of rna splicing | GO:0033119 | 12 | 0.255 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.251 | |
| histone h4 k20 trimethylation | GO:0034773 | 2 | 0.251 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.249 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.245 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.245 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.244 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.241 | |
| nuclear division | GO:0000280 | 158 | 0.240 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.239 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.232 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.225 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.220 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.220 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.220 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.217 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.214 | |
| stem cell differentiation | GO:0048863 | 268 | 0.213 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.212 | |
| negative regulation of mrna metabolic process | GO:1903312 | 13 | 0.211 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.209 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.208 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.204 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.200 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.198 | |
| mrna transport | GO:0051028 | 13 | 0.197 | |
| demethylation | GO:0070988 | 23 | 0.196 | |
| dna conformation change | GO:0071103 | 37 | 0.193 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.193 | |
| dna packaging | GO:0006323 | 30 | 0.191 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.190 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.187 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.185 | |
| transcription coupled nucleotide excision repair | GO:0006283 | 2 | 0.177 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.175 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.174 | |
| regulation of protein localization | GO:0032880 | 231 | 0.174 | Human |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.165 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.160 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.160 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.159 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.157 | Human |
| telomere maintenance | GO:0000723 | 19 | 0.155 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.154 | |
| gene silencing by rna | GO:0031047 | 19 | 0.151 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.151 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.149 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.149 | Human Mouse |
| mrna metabolic process | GO:0016071 | 84 | 0.147 | |
| organelle fission | GO:0048285 | 170 | 0.143 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.136 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.136 | Mouse |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.135 | |
| microtubule based process | GO:0007017 | 236 | 0.133 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.131 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.127 | |
| chromatin disassembly | GO:0031498 | 1 | 0.126 | |
| positive regulation of chromosome segregation | GO:0051984 | 4 | 0.125 | |
| spliceosomal complex assembly | GO:0000245 | 6 | 0.124 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.122 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.121 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.119 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.118 | Human |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.118 | |
| positive regulation of nucleocytoplasmic transport | GO:0046824 | 30 | 0.118 | Human |
| intracellular transport of virus | GO:0075733 | 1 | 0.117 | |
| genitalia development | GO:0048806 | 37 | 0.116 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.115 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.114 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.114 | |
| nucleobase containing compound transport | GO:0015931 | 27 | 0.113 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.109 | |
| chromatin remodeling | GO:0006338 | 32 | 0.108 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.107 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.107 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.104 | |
| negative regulation of ras protein signal transduction | GO:0046580 | 18 | 0.103 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.103 | |
| dna dealkylation | GO:0035510 | 11 | 0.101 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.101 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.099 | |
| gtp metabolic process | GO:0046039 | 144 | 0.098 | |
| maintenance of apical basal cell polarity | GO:0035090 | 3 | 0.097 | |
| regulation of dna damage checkpoint | GO:2000001 | 3 | 0.096 | |
| maintenance of epithelial cell apical basal polarity | GO:0045199 | 2 | 0.096 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.095 | |
| chemotaxis | GO:0006935 | 247 | 0.093 | Fly |
| protein modification by small protein removal | GO:0070646 | 21 | 0.091 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.089 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.089 | |
| gtp catabolic process | GO:0006184 | 143 | 0.089 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.089 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.088 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.088 | |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.086 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.086 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.086 | |
| rna interference | GO:0016246 | 2 | 0.085 | |
| protein targeting | GO:0006605 | 143 | 0.083 | Human |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.083 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.081 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.079 | |
| dna methylation on cytosine | GO:0032776 | 5 | 0.079 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.078 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.078 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.076 | Human |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.076 | |
| gonad development | GO:0008406 | 141 | 0.074 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.073 | Human |
| germ cell development | GO:0007281 | 185 | 0.072 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.072 | |
| multicellular organism growth | GO:0035264 | 161 | 0.072 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.071 | |
| neuron projection guidance | GO:0097485 | 141 | 0.067 | Fly |
| cytoplasmic transport | GO:0016482 | 234 | 0.067 | Human |
| nucleoside catabolic process | GO:0009164 | 206 | 0.067 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.067 | Human |
| organophosphate catabolic process | GO:0046434 | 232 | 0.066 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.065 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.063 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.062 | |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.061 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.061 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.061 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.061 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.061 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.060 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.059 | Mouse |
| protein localization to chromatin | GO:0071168 | 3 | 0.059 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.058 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.056 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.056 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.056 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.055 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.054 | Human |
| intracellular protein transport | GO:0006886 | 204 | 0.054 | Human |
| ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway | GO:0043162 | 3 | 0.052 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.052 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.052 | Human |
| translation | GO:0006412 | 93 | 0.051 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.051 | |
| camera type eye development | GO:0043010 | 266 | 0.051 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.050 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.049 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.049 | |
| nucleotide excision repair | GO:0006289 | 13 | 0.048 | |
| endocytosis | GO:0006897 | 168 | 0.047 | |
| gland development | GO:0048732 | 330 | 0.047 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.046 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.046 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.046 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.045 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.045 | Human |
| multi multicellular organism process | GO:0044706 | 109 | 0.044 | |
| negative regulation of chromatin modification | GO:1903309 | 19 | 0.044 | |
| positive regulation of retinoic acid receptor signaling pathway | GO:0048386 | 3 | 0.044 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.044 | |
| nuclear export | GO:0051168 | 34 | 0.043 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.042 | |
| protein import into nucleus | GO:0006606 | 95 | 0.042 | Human |
| macromolecule catabolic process | GO:0009057 | 281 | 0.042 | Mouse |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.042 | |
| nuclear transport | GO:0051169 | 139 | 0.042 | Human |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.042 | Human |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.041 | |
| protein localization to organelle | GO:0033365 | 185 | 0.041 | Human |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.041 | Mouse |
| meiotic cell cycle | GO:0051321 | 122 | 0.041 | |
| rna splicing | GO:0008380 | 54 | 0.040 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.039 | |
| ribonucleoprotein complex subunit organization | GO:0071826 | 28 | 0.039 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.038 | |
| locomotory behavior | GO:0007626 | 195 | 0.038 | |
| spermatid differentiation | GO:0048515 | 115 | 0.038 | |
| viral gene expression | GO:0019080 | 3 | 0.037 | |
| heterochromatin assembly | GO:0031507 | 2 | 0.037 | |
| focal adhesion assembly | GO:0048041 | 19 | 0.037 | |
| regulation of cell motility | GO:2000145 | 236 | 0.036 | |
| learning | GO:0007612 | 98 | 0.036 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.035 | |
| learning or memory | GO:0007611 | 148 | 0.035 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.035 | |
| protein deubiquitination | GO:0016579 | 19 | 0.034 | |
| positive regulation of growth | GO:0045927 | 104 | 0.034 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.033 | |
| cognition | GO:0050890 | 149 | 0.033 | |
| cellular homeostasis | GO:0019725 | 240 | 0.033 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.033 | |
| regulation of cell cycle checkpoint | GO:1901976 | 9 | 0.033 | |
| mesenchyme development | GO:0060485 | 152 | 0.033 | |
| connective tissue development | GO:0061448 | 179 | 0.033 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.033 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.033 | Human |
| primary mirna processing | GO:0031053 | 1 | 0.032 | |
| protein ubiquitination | GO:0016567 | 171 | 0.032 | Human Mouse |
| rna transport | GO:0050658 | 18 | 0.032 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.032 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.031 | |
| histone h4 k20 methylation | GO:0034770 | 8 | 0.031 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.031 | |
| response to alcohol | GO:0097305 | 48 | 0.031 | Mouse |
| protein import | GO:0017038 | 101 | 0.030 | Human |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.030 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.030 | |
| blastocyst growth | GO:0001832 | 23 | 0.030 | |
| response to radiation | GO:0009314 | 165 | 0.029 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.028 | |
| nuclear import | GO:0051170 | 95 | 0.028 | Human |
| blastocyst hatching | GO:0001835 | 4 | 0.028 | |
| regulation of binding | GO:0051098 | 111 | 0.028 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.028 | Human |
| cellular response to peptide | GO:1901653 | 92 | 0.027 | |
| protein complex disassembly | GO:0043241 | 40 | 0.027 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.027 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.027 | |
| establishment of rna localization | GO:0051236 | 18 | 0.026 | |
| response to topologically incorrect protein | GO:0035966 | 25 | 0.026 | |
| axonal fasciculation | GO:0007413 | 15 | 0.026 | |
| recombinational repair | GO:0000725 | 21 | 0.026 | |
| rhythmic process | GO:0048511 | 174 | 0.025 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.025 | Human |
| regulation of rna export from nucleus | GO:0046831 | 4 | 0.025 | |
| histone h2a ubiquitination | GO:0033522 | 3 | 0.025 | |
| rna export from nucleus | GO:0006405 | 15 | 0.025 | |
| positive regulation of rna splicing | GO:0033120 | 12 | 0.024 | |
| entry into host | GO:0044409 | 15 | 0.024 | |
| response to light stimulus | GO:0009416 | 135 | 0.024 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.024 | |
| single organism nuclear import | GO:1902593 | 95 | 0.024 | Human |
| peptidyl lysine dimethylation | GO:0018027 | 6 | 0.023 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.023 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.023 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.023 | |
| dna templated transcription elongation | GO:0006354 | 13 | 0.023 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.023 | Mouse |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.023 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.023 | |
| dendrite development | GO:0016358 | 115 | 0.023 | Fly |
| meiotic nuclear division | GO:0007126 | 115 | 0.022 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.022 | |
| base excision repair | GO:0006284 | 9 | 0.022 | |
| spermatid development | GO:0007286 | 108 | 0.022 | |
| negative regulation of androgen receptor signaling pathway | GO:0060766 | 3 | 0.022 | |
| dna dependent dna replication maintenance of fidelity | GO:0045005 | 3 | 0.022 | |
| regulation of antimicrobial peptide production | GO:0002784 | 1 | 0.021 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.021 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.021 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.021 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.021 | |
| regulation of chromatin binding | GO:0035561 | 7 | 0.021 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.021 | |
| regulation of intracellular steroid hormone receptor signaling pathway | GO:0033143 | 18 | 0.021 | |
| atp metabolic process | GO:0046034 | 75 | 0.021 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.021 | |
| primary neural tube formation | GO:0014020 | 95 | 0.020 | |
| motor neuron migration | GO:0097475 | 4 | 0.020 | |
| regulation of protein transport | GO:0051223 | 163 | 0.020 | Human |
| cytoplasmic translational initiation | GO:0002183 | 3 | 0.020 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.020 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.020 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.020 | |
| stem cell development | GO:0048864 | 219 | 0.019 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.019 | |
| defense response to bacterium | GO:0042742 | 119 | 0.019 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.019 | |
| trna wobble uridine modification | GO:0002098 | 2 | 0.019 | |
| viral transcription | GO:0019083 | 3 | 0.019 | |
| skeletal system development | GO:0001501 | 356 | 0.019 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.019 | Mouse |
| regulation of g2 m transition of mitotic cell cycle | GO:0010389 | 10 | 0.019 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.019 | |
| segmentation | GO:0035282 | 93 | 0.019 | |
| dna recombination | GO:0006310 | 92 | 0.019 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.019 | Mouse |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.018 | |
| viral process | GO:0016032 | 41 | 0.018 | Human |
| female gamete generation | GO:0007292 | 74 | 0.018 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.018 | |
| spindle organization | GO:0007051 | 28 | 0.018 | |
| mrna processing | GO:0006397 | 63 | 0.018 | |
| molting cycle | GO:0042303 | 90 | 0.018 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.018 | |
| negative regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035359 | 3 | 0.018 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.017 | |
| localization within membrane | GO:0051668 | 4 | 0.017 | |
| pole plasm assembly | GO:0007315 | 2 | 0.017 | |
| response to acid chemical | GO:0001101 | 111 | 0.017 | |
| stem cell fate specification | GO:0048866 | 3 | 0.017 | |
| body morphogenesis | GO:0010171 | 45 | 0.017 | |
| mitotic g2 dna damage checkpoint | GO:0007095 | 8 | 0.017 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.017 | |
| fat cell differentiation | GO:0045444 | 160 | 0.017 | |
| heart process | GO:0003015 | 94 | 0.017 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.016 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.016 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.016 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.016 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.016 | |
| monoubiquitinated histone deubiquitination | GO:0035521 | 1 | 0.016 | |
| negative regulation of histone h3 k9 methylation | GO:0051573 | 4 | 0.016 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.016 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.016 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.016 | |
| histone h3 k14 acetylation | GO:0044154 | 3 | 0.016 | |
| negative regulation of nucleotide catabolic process | GO:0030812 | 9 | 0.016 | |
| establishment of planar polarity | GO:0001736 | 28 | 0.016 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.016 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.015 | |
| innate immune response | GO:0045087 | 157 | 0.015 | Human |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.015 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.015 | |
| peptide secretion | GO:0002790 | 114 | 0.015 | |
| regulation of transposition | GO:0010528 | 2 | 0.015 | |
| peptidyl lysine monomethylation | GO:0018026 | 1 | 0.015 | |
| adult behavior | GO:0030534 | 135 | 0.015 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.015 | |
| maintenance of location | GO:0051235 | 89 | 0.015 | |
| immune effector process | GO:0002252 | 321 | 0.015 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.015 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.015 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.015 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.014 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.014 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.014 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.014 | Human |
| telencephalon development | GO:0021537 | 186 | 0.014 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.014 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.014 | |
| heterochromatin organization | GO:0070828 | 4 | 0.014 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.014 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.014 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.014 | |
| positive regulation of binding | GO:0051099 | 49 | 0.014 | |
| neuron migration | GO:0001764 | 122 | 0.014 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.014 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.014 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.014 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.013 | |
| transmembrane transport | GO:0055085 | 412 | 0.013 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.013 | |
| hatching | GO:0035188 | 4 | 0.013 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.013 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.013 | Human |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.013 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 7 | 0.013 | |
| cellular response to interleukin 4 | GO:0071353 | 21 | 0.013 | |
| pharynx development | GO:0060465 | 1 | 0.013 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.013 | Mouse |
| establishment or maintenance of neuroblast polarity | GO:0045196 | 1 | 0.013 | |
| cell junction assembly | GO:0034329 | 52 | 0.013 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.013 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.013 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.013 | |
| gliogenesis | GO:0042063 | 141 | 0.013 | |
| negative regulation of cell adhesion | GO:0007162 | 45 | 0.013 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.013 | |
| epidermis development | GO:0008544 | 187 | 0.013 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.013 | |
| embryonic axis specification | GO:0000578 | 30 | 0.013 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.013 | |
| organ growth | GO:0035265 | 117 | 0.012 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.012 | |
| response to interleukin 4 | GO:0070670 | 23 | 0.012 | |
| hair follicle placode formation | GO:0060789 | 5 | 0.012 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.012 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.012 | |
| response to oxidative stress | GO:0006979 | 123 | 0.012 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.012 | |
| positive regulation of dna templated transcription initiation | GO:2000144 | 5 | 0.012 | |
| cell growth | GO:0016049 | 130 | 0.012 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.012 | |
| protein processing | GO:0016485 | 163 | 0.012 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.012 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.012 | |
| negative regulation of histone modification | GO:0031057 | 18 | 0.012 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.011 | |
| inner cell mass cell proliferation | GO:0001833 | 15 | 0.011 | |
| oogenesis | GO:0048477 | 56 | 0.011 | |
| positive regulation of histone h3 k4 methylation | GO:0051571 | 5 | 0.011 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.011 | |
| positive regulation of gluconeogenesis by positive regulation of transcription from rna polymerase ii promoter | GO:0035948 | 5 | 0.011 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.011 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.011 | |
| response to amino acid | GO:0043200 | 37 | 0.011 | |
| intrahepatic bile duct development | GO:0035622 | 2 | 0.011 | |
| histone acetylation | GO:0016573 | 41 | 0.011 | |
| calcium ion transport | GO:0006816 | 159 | 0.011 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.011 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.011 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.011 | |
| cell recognition | GO:0008037 | 83 | 0.011 | |
| s adenosylhomocysteine metabolic process | GO:0046498 | 1 | 0.011 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.011 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.011 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.011 | |
| multi organism reproductive behavior | GO:0044705 | 29 | 0.011 | |
| regulation of interleukin 2 secretion | GO:1900040 | 6 | 0.011 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.011 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.011 | |
| dna unwinding involved in dna replication | GO:0006268 | 5 | 0.011 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.011 | |
| jak stat cascade | GO:0007259 | 42 | 0.011 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.010 | |
| atp catabolic process | GO:0006200 | 55 | 0.010 | |
| response to nerve growth factor | GO:1990089 | 3 | 0.010 | |
| embryonic placenta development | GO:0001892 | 98 | 0.010 | |
| response to peptide hormone | GO:0043434 | 127 | 0.010 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.010 | |
